Allotment of 49,350 Equity Shares of face value of Rs. 2/- per share pursuant to the Exercise of Options under Advanced Enzyme Technologies Limited - Employees Stock Options Scheme 2022.
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Advanced Enzyme Technologies Ltd held its Board meeting on May 09, 2026, approving the audited annual financial results for FY 2025-26 and allotting 49,350 equity shares under the Employee Stock Option Scheme 2022. The company's consolidated revenue from operations grew by 17.1% to Rs. 7,457.57 million from Rs. 6,369.10 million in the previous year. Profit after tax (PAT) increased by 29.6% to Rs. 1,736.08 million compared to Rs. 1,339.74 million in FY 2024-25. The Board recommended a final dividend of Rs. 1.35 per share (67.5% on face value of Rs. 2) for FY 2025-26 and deferred an interim dividend to preserve capital for strategic opportunities. Statutory auditors M S K A & Associates LLP issued an unmodified (clean) opinion. The paid-up share capital increased from Rs. 22,38,53,600 to Rs. 22,39,52,300.
Strong financial performance with 29.6% PAT growth and 17% revenue growth is positive for shareholders. The ESOP allotment and dividend recommendation reflect employee retention and shareholder reward. The decision to defer interim dividend while maintaining final dividend suggests prudent capital management for future strategic actions.